A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 16, 2025

Primary Completion Date

October 29, 2025

Study Completion Date

October 29, 2025

Conditions

Healthy Participants

Interventions

DRUG

INCB161734

Oral; Tablet

DRUG

Itraconazole

Oral; Tablet

DRUG

Rifampin

Oral; Tablet

DRUG

Esomeprazole

Oral; Tablet

DRUG

Famotidine

Oral; Tablet

Trial Locations (1)

RECRUITING

Fortrea Clinical Research Unit Ltd Labcorp Clinical Research Unit Limited Madison, Madison